PURPOSE OF REVIEW: Although it has been known for some time that increases in body mass enhance aldosterone secretion, particularly in women, the origin of this elevation in aldosterone production is not well defined. Adipocyte-derived factors have emerged as potential candidates to increase aldosterone production in obesity. RECENT FINDINGS: Emerging evidence suggests the presence of a mechanistic link in which the adipocyte-derived hormone leptin stimulates aldosterone production in obesity, thereby creating a positive feedback loop for obesity-associated cardiovascular disease. In addition, recent reports give credence to the concept that this leptin-aldosterone stimulation pathway in obesity is an underlying mechanism for sex-discrepancies in obesity-associated cardiovascular disease. SUMMARY: Leptin appears as a new direct regulator of adrenal aldosterone production and leptin-mediated aldosterone production is a novel candidate mechanism underlying obesity-associated hypertension, particularly in females.
PURPOSE OF REVIEW: Although it has been known for some time that increases in body mass enhance aldosterone secretion, particularly in women, the origin of this elevation in aldosterone production is not well defined. Adipocyte-derived factors have emerged as potential candidates to increase aldosterone production in obesity. RECENT FINDINGS: Emerging evidence suggests the presence of a mechanistic link in which the adipocyte-derived hormone leptin stimulates aldosterone production in obesity, thereby creating a positive feedback loop for obesity-associated cardiovascular disease. In addition, recent reports give credence to the concept that this leptin-aldosterone stimulation pathway in obesity is an underlying mechanism for sex-discrepancies in obesity-associated cardiovascular disease. SUMMARY:Leptin appears as a new direct regulator of adrenal aldosterone production and leptin-mediated aldosterone production is a novel candidate mechanism underlying obesity-associated hypertension, particularly in females.
Authors: G Andronico; S Cottone; M T Mangano; R Ferraro-Mortellaro; G Baiardi; N Grassi; L Ferrara; G Mulé; G Cerasola Journal: Int J Obes Relat Metab Disord Date: 2001-02
Authors: Murielle Bochud; Jürg Nussberger; Pascal Bovet; Marc R Maillard; Robert C Elston; Fred Paccaud; Conrad Shamlaye; Michel Burnier Journal: Hypertension Date: 2006-06-19 Impact factor: 10.190
Authors: Ashraf H Ahmed; Richard D Gordon; Gregory Ward; Martin Wolley; Cynthia Kogovsek; Michael Stowasser Journal: Clin Endocrinol (Oxf) Date: 2015-02-03 Impact factor: 3.478
Authors: John E Hall; Alan J Mouton; Alexandre A da Silva; Ana C M Omoto; Zhen Wang; Xuan Li; Jussara M do Carmo Journal: Cardiovasc Res Date: 2021-07-07 Impact factor: 10.787
Authors: Alexandre A da Silva; Mark A Pinkerton; Frank T Spradley; Ana C Palei; John E Hall; Jussara M do Carmo Journal: Am J Physiol Regul Integr Comp Physiol Date: 2020-11-18 Impact factor: 3.619